{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T10:41:55Z","timestamp":1762252915959,"version":"build-2065373602"},"reference-count":231,"publisher":"Elsevier","isbn-type":[{"type":"print","value":"9780128177389"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81672585"],"award-info":[{"award-number":["81672585"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1016\/bs.pmbts.2018.12.003","type":"book-chapter","created":{"date-parts":[[2019,1,27]],"date-time":"2019-01-27T05:45:07Z","timestamp":1548567907000},"page":"59-92","source":"Crossref","is-referenced-by-count":12,"title":["Proteoglycans as miscommunication biomarkers for cancer diagnosis"],"prefix":"10.1016","member":"78","reference":[{"issue":"10053","key":"10.1016\/bs.pmbts.2018.12.003_bb0010","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(16)31678-6","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"388","year":"2016","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/bs.pmbts.2018.12.003_bb0015","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nrc1041","article-title":"The case for early detection","volume":"3","author":"Etzioni","year":"2003","journal-title":"Nat Rev Cancer"},{"issue":"14","key":"10.1016\/bs.pmbts.2018.12.003_bb0020","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/jnci\/djn249","article-title":"Ontario institute offers new model of cancer research","volume":"100","author":"Garber","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/bs.pmbts.2018.12.003_bb0025","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.12688\/f1000research.13440.1","article-title":"Can circulating tumor DNA be used for direct and early stage cancer detection?","volume":"6","author":"Diamandis","year":"2017","journal-title":"F1000Res"},{"issue":"1","key":"10.1016\/bs.pmbts.2018.12.003_bb0030","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12916-017-0921-6","article-title":"Circulating tumor DNA for personalized lung cancer monitoring","volume":"15","author":"Fiala","year":"2017","journal-title":"BMC Med"},{"key":"10.1016\/bs.pmbts.2018.12.003_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1877-1173(10)93001-9","article-title":"Glycosaminoglycan (GAG) biosynthesis and GAG-binding proteins","volume":"93","author":"Zhang","year":"2010","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"5","key":"10.1016\/bs.pmbts.2018.12.003_bb0040","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0959-440X(96)80034-0","article-title":"Influence of core protein sequence on glycosaminoglycan assembly","volume":"6","author":"Esko","year":"1996","journal-title":"Curr Opin Struct Biol"},{"issue":"19","key":"10.1016\/bs.pmbts.2018.12.003_bb0045","doi-asserted-by":"crossref","first-page":"10359","DOI":"10.1073\/pnas.97.19.10359","article-title":"Sequencing of 3-O-sulfate containing heparin decasaccharides with a partial antithrombin III binding site","volume":"97","author":"Shriver","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/bs.pmbts.2018.12.003_bb0050","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1021\/ac0263418","article-title":"Tandem mass spectrometry of sulfated heparin-like glycosaminoglycan oligosaccharides","volume":"75","author":"Zaia","year":"2003","journal-title":"Anal Chem"},{"issue":"25","key":"10.1016\/bs.pmbts.2018.12.003_bb0055","doi-asserted-by":"crossref","first-page":"22438","DOI":"10.1074\/jbc.M111401200","article-title":"The structural motif in chondroitin sulfate for adhesion of Plasmodium falciparum-infected erythrocytes comprises disaccharide units of 4-O-sulfated and non-sulfated N-acetylgalactosamine linked to glucuronic acid","volume":"277","author":"Chai","year":"2002","journal-title":"J Biol Chem"},{"issue":"16","key":"10.1016\/bs.pmbts.2018.12.003_bb0060","doi-asserted-by":"crossref","first-page":"12539","DOI":"10.1074\/jbc.M010291200","article-title":"10E4 antigen of Scrapie lesions contains an unusual nonsulfated heparan motif","volume":"276","author":"Leteux","year":"2001","journal-title":"J Biol Chem"},{"issue":"14","key":"10.1016\/bs.pmbts.2018.12.003_bb0065","doi-asserted-by":"crossref","first-page":"9451","DOI":"10.1016\/S0021-9258(19)50108-9","article-title":"Cell surface heparan sulfate proteoglycans","volume":"267","author":"Yanagishita","year":"1992","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/bs.pmbts.2018.12.003_bb0070","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1023\/A:1011375624902","article-title":"Molecular properties and involvement of heparanase in cancer progression and mammary gland morphogenesis","volume":"6","author":"Zcharia","year":"2001","journal-title":"J Mammary Gland Biol Neoplasia"},{"issue":"8","key":"10.1016\/bs.pmbts.2018.12.003_bb0075","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0300-9084(01)01318-9","article-title":"Molecular properties and involvement of heparanase in cancer progression and normal development","volume":"83","author":"Vlodavsky","year":"2001","journal-title":"Biochimie"},{"issue":"3","key":"10.1016\/bs.pmbts.2018.12.003_bb0080","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1172\/JCI13662","article-title":"Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis","volume":"108","author":"Vlodavsky","year":"2001","journal-title":"J Clin Invest"},{"issue":"24","key":"10.1016\/bs.pmbts.2018.12.003_bb0085","doi-asserted-by":"crossref","first-page":"12287","DOI":"10.1021\/acs.analchem.6b03469","article-title":"Evaluating tumor-associated activity of extracellular sulfatase by analyzing naturally occurring substrate in tumor microenvironment of hepatocellular carcinoma","volume":"88","author":"Yu","year":"2016","journal-title":"Anal Chem"},{"issue":"28","key":"10.1016\/bs.pmbts.2018.12.003_bb0090","doi-asserted-by":"crossref","first-page":"43177","DOI":"10.18632\/oncotarget.9506","article-title":"Expression of the extracellular sulfatase SULF2 is associated with squamous cell carcinoma of the head and neck","volume":"7","author":"Flowers","year":"2016","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/bs.pmbts.2018.12.003_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105143","article-title":"Oligosaccharide substrate preferences of human extracellular sulfatase Sulf2 using liquid chromatography-mass spectrometry based glycomics approaches","volume":"9","author":"Huang","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/bs.pmbts.2018.12.003_bb0100","doi-asserted-by":"crossref","first-page":"e16689","DOI":"10.1371\/journal.pone.0016689","article-title":"Glycomics analysis of mammalian heparan sulfates modified by the human extracellular sulfatase HSulf2","volume":"6","author":"Staples","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/bs.pmbts.2018.12.003_bb0105","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2091-7-2","article-title":"HSulf-2, an extracellular endoglucosamine-6-sulfatase, selectively mobilizes heparin-bound growth factors and chemokines: effects on VEGF, FGF-1, and SDF-1","volume":"7","author":"Uchimura","year":"2006","journal-title":"BMC Biochem"},{"issue":"5535","key":"10.1016\/bs.pmbts.2018.12.003_bb0110","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1126\/science.293.5535.1663","article-title":"Regulation of Wnt signaling and embryo patterning by an extracellular sulfatase","volume":"293","author":"Dhoot","year":"2001","journal-title":"Science"},{"issue":"4","key":"10.1016\/bs.pmbts.2018.12.003_bb0115","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1158\/2159-8290.CD-11-0136","article-title":"Targeting the tumor microenvironment in cancer: why hyaluronidase deserves a second look","volume":"1","author":"Whatcott","year":"2011","journal-title":"Cancer Discov"},{"issue":"1","key":"10.1016\/bs.pmbts.2018.12.003_bb0120","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.eururo.2009.03.057","article-title":"HYAL-1 hyaluronidase: a potential prognostic indicator for progression to muscle invasion and recurrence in bladder cancer","volume":"57","author":"Kramer","year":"2010","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/bs.pmbts.2018.12.003_bb0125","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.semcancer.2008.03.017","article-title":"Hyaluronidases in cancer biology","volume":"18","author":"Stern","year":"2008","journal-title":"Semin Cancer Biol"},{"issue":"12","key":"10.1016\/bs.pmbts.2018.12.003_bb0130","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/j.biocel.2006.06.004","article-title":"Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis","volume":"38","author":"Ilan","year":"2006","journal-title":"Int J Biochem Cell Biol"},{"issue":"7","key":"10.1016\/bs.pmbts.2018.12.003_bb0135","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nrc1649","article-title":"The sweet and sour of cancer: glycans as novel therapeutic targets","volume":"5","author":"Fuster","year":"2005","journal-title":"Nat Rev Cancer"},{"issue":"suppl 2","key":"10.1016\/bs.pmbts.2018.12.003_bb0140","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1016\/S0049-3848(14)50016-3","article-title":"Glycosaminoglycans in cancer treatment","volume":"133","author":"Belting","year":"2014","journal-title":"Thromb Res"},{"issue":"7","key":"10.1016\/bs.pmbts.2018.12.003_bb0145","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/j.1742-4658.2012.08529.x","article-title":"Glycosaminoglycans: key players in cancer cell biology and treatment","volume":"279","author":"Afratis","year":"2012","journal-title":"FEBS J"},{"key":"10.1016\/bs.pmbts.2018.12.003_bb0150","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1146\/annurev-biochem-060713-035314","article-title":"Demystifying heparan sulfate\u2013protein interactions","volume":"83","author":"Xu","year":"2014","journal-title":"Annu Rev Biochem"},{"issue":"44","key":"10.1016\/bs.pmbts.2018.12.003_bb0155","doi-asserted-by":"crossref","first-page":"13570","DOI":"10.1021\/bi971125s","article-title":"Glycosaminoglycans mediate cell surface oligomerization of chemokines","volume":"36","author":"Hoogewerf","year":"1997","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/bs.pmbts.2018.12.003_bb0160","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1073\/pnas.032497699","article-title":"Structural diversity of heparan sulfate binding domains in chemokines","volume":"99","author":"Lortat-Jacob","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/bs.pmbts.2018.12.003_bb0165","doi-asserted-by":"crossref","first-page":"645","DOI":"10.2741\/3638","article-title":"Chemokine patterning by glycosaminoglycans and interceptors","volume":"15","author":"Rot","year":"2010","journal-title":"Front Biosci"},{"issue":"9","key":"10.1016\/bs.pmbts.2018.12.003_bb0170","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1172\/JCI119377","article-title":"Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated?","volume":"99","author":"Rosenberg","year":"1997","journal-title":"J Clin Invest"},{"issue":"26","key":"10.1016\/bs.pmbts.2018.12.003_bb0175","doi-asserted-by":"crossref","first-page":"14683","DOI":"10.1073\/pnas.94.26.14683","article-title":"The anticoagulant activation of antithrombin by heparin","volume":"94","author":"Jin","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/bs.pmbts.2018.12.003_bb0180","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1126\/scitranslmed.aai9044","article-title":"Glycosaminoglycan-based hydrogels capture inflammatory chemokines and rescue defective wound healing in mice","volume":"9","author":"Lohmann","year":"2017","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/bs.pmbts.2018.12.003_bb0185","first-page":"99","article-title":"The effect on wound healing of glycosaminoglycan polysulfate","volume":"40","author":"Elling","year":"1990","journal-title":"Arzneimittelforschung"},{"issue":"2","key":"10.1016\/bs.pmbts.2018.12.003_bb0190","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.matbio.2009.11.002","article-title":"Hyaluronan oligosaccharides promote excisional wound healing through enhanced angiogenesis","volume":"29","author":"Gao","year":"2010","journal-title":"Matrix Biol"},{"issue":"6","key":"10.1016\/bs.pmbts.2018.12.003_bb0195","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.pharep.2016.07.001","article-title":"Hyaluronan oligosaccharides promote diabetic wound healing by increasing angiogenesis","volume":"68","author":"Wang","year":"2016","journal-title":"Pharmacol Rep"},{"issue":"5647","key":"10.1016\/bs.pmbts.2018.12.003_bb0200","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1126\/science.1090497","article-title":"Mammalian brain morphogenesis and midline axon guidance require heparan sulfate","volume":"302","author":"Inatani","year":"2003","journal-title":"Science"},{"key":"10.1016\/bs.pmbts.2018.12.003_bb0205","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1877-1173(10)93010-X","article-title":"Hepatic heparan sulfate proteoglycans and endocytic clearance of triglyceride-rich lipoproteins","volume":"93","author":"Foley","year":"2010","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"1","key":"10.1016\/bs.pmbts.2018.12.003_bb0210","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2174\/187152008783330824","article-title":"Heparin, heparan sulfate and heparanase in cancer: remedy for metastasis?","volume":"8","author":"Li","year":"2008","journal-title":"Anti Cancer Agents Med Chem"},{"issue":"2","key":"10.1016\/bs.pmbts.2018.12.003_bb0215","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/scdb.2000.0241","article-title":"Heparan sulfate proteoglycans in invasion and metastasis","volume":"12","author":"Sanderson","year":"2001","journal-title":"Semin Cell Dev Biol"},{"issue":"3","key":"10.1016\/bs.pmbts.2018.12.003_bb0220","first-page":"443","article-title":"Heparan sulfate in angiogenesis: a target for therapy","volume":"17","author":"van Wijk","year":"2014","journal-title":"Angiogenesis"},{"issue":"1","key":"10.1016\/bs.pmbts.2018.12.003_bb0225","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1186\/s12885-018-4532-1","article-title":"Dynamic Hyaluronan drives liver endothelial cells towards angiogenesis","volume":"18","author":"Ghose","year":"2018","journal-title":"BMC Cancer"},{"issue":"12","key":"10.1016\/bs.pmbts.2018.12.003_bb0230","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1038\/cti.2015.35","article-title":"The immunological effect of hyaluronan in tumor angiogenesis","volume":"4","author":"Spinelli","year":"2015","journal-title":"Clin Transl Immunol"},{"issue":"2","key":"10.1016\/bs.pmbts.2018.12.003_bb0235","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/jbm.b.30499","article-title":"Preparation and characterization of hyaluronan oligosaccharides for angiogenesis study","volume":"78","author":"Gao","year":"2006","journal-title":"J Biomed Mater Res B Appl Biomater"},{"issue":"5","key":"10.1016\/bs.pmbts.2018.12.003_bb0240","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/ijc.20059","article-title":"Hyaluronan, angiogenesis and malignant disease","volume":"109","author":"Slevin","year":"2004","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/bs.pmbts.2018.12.003_bb0245","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0168-9525(00)01997-1","article-title":"Proteoglycans and pattern formation: sugar biochemistry meets developmental genetics","volume":"16","author":"Selleck","year":"2000","journal-title":"Trends Genet"},{"issue":"4","key":"10.1016\/bs.pmbts.2018.12.003_bb0250","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41374-017-0015-2","article-title":"Endothelial heparan sulfate deficiency reduces inflammation and fibrosis in murine diabetic nephropathy","volume":"98","author":"Talsma","year":"2018","journal-title":"Lab Invest"},{"issue":"9","key":"10.1016\/bs.pmbts.2018.12.003_bb0255","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/ni1233","article-title":"Endothelial heparan sulfate deficiency impairs L-selectin- and chemokine-mediated neutrophil trafficking during inflammatory responses","volume":"6","author":"Wang","year":"2005","journal-title":"Nat Immunol"},{"issue":"6","key":"10.1016\/bs.pmbts.2018.12.003_bb0260","doi-asserted-by":"crossref","first-page":"H1143","DOI":"10.1152\/ajpheart.00209.2017","article-title":"Hypoxia promotes primitive glycosaminoglycan-rich extracellular matrix composition in developing heart valves","volume":"313","author":"Amofa","year":"2017","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"10.1016\/bs.pmbts.2018.12.003_bb0265","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0092-8674(00)80058-6","article-title":"A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry","volume":"99","author":"Shukla","year":"1999","journal-title":"Cell"},{"issue":"11","key":"10.1016\/bs.pmbts.2018.12.003_bb0270","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1093\/infdis\/jiy081","article-title":"The role of heparan sulfate proteoglycans as an attachment factor for rabies virus entry and infection","volume":"217","author":"Sasaki","year":"2018","journal-title":"J Infect Dis"},{"issue":"15","key":"10.1016\/bs.pmbts.2018.12.003_bb0275","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00503-17","article-title":"Heparan sulfate proteoglycan is an important attachment factor for cell entry of akabane and schmallenberg viruses","volume":"91","author":"Murakami","year":"2017","journal-title":"J Virol"},{"issue":"8","key":"10.1016\/bs.pmbts.2018.12.003_bb0280","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1128\/JVI.00024-14","article-title":"Heparan sulfate in baculovirus binding and entry of mammalian cells","volume":"88","author":"Nasimuzzaman","year":"2014","journal-title":"J Virol"},{"issue":"21","key":"10.1016\/bs.pmbts.2018.12.003_bb0285","doi-asserted-by":"crossref","first-page":"11426","DOI":"10.1128\/JVI.01721-13","article-title":"Multiple heparan sulfate binding site engagements are required for the infectious entry of human papillomavirus type 16","volume":"87","author":"Richards","year":"2013","journal-title":"J Virol"},{"issue":"24","key":"10.1016\/bs.pmbts.2018.12.003_bb0290","doi-asserted-by":"crossref","first-page":"13767","DOI":"10.1128\/JVI.01364-12","article-title":"Heparan sulfate facilitates Rift Valley fever virus entry into the cell","volume":"86","author":"de Boer","year":"2012","journal-title":"J Virol"},{"issue":"18","key":"10.1016\/bs.pmbts.2018.12.003_bb0295","doi-asserted-by":"crossref","first-page":"10028","DOI":"10.1128\/JVI.00051-12","article-title":"Heparan sulfate is an attachment factor for foamy virus entry","volume":"86","author":"Plochmann","year":"2012","journal-title":"J Virol"},{"issue":"22","key":"10.1016\/bs.pmbts.2018.12.003_bb0300","doi-asserted-by":"crossref","first-page":"14451","DOI":"10.1128\/JVI.79.22.14451-14456.2005","article-title":"Murine coronavirus with an extended host range uses heparan sulfate as an entry receptor","volume":"79","author":"de Haan","year":"2005","journal-title":"J Virol"},{"issue":"20","key":"10.1016\/bs.pmbts.2018.12.003_bb0305","doi-asserted-by":"crossref","first-page":"12692","DOI":"10.1128\/JVI.79.20.12692-12702.2005","article-title":"Heparan sulfate proteoglycans mediate attachment and entry of human T-cell leukemia virus type 1 virions into CD4+ T cells","volume":"79","author":"Jones","year":"2005","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/bs.pmbts.2018.12.003_bb0310","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0042-6822(02)00097-1","article-title":"Role of heparan sulfate for attachment and entry of tick-borne encephalitis virus","volume":"308","author":"Kroschewski","year":"2003","journal-title":"Virology"},{"issue":"1","key":"10.1016\/bs.pmbts.2018.12.003_bb0315","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1128\/iai.65.1.78-88.1997","article-title":"Host cell heparan sulfate proteoglycans mediate attachment and entry of listeria monocytogenes, and the listerial surface protein ActA is involved in heparan sulfate receptor recognition","volume":"65","author":"Alvarez-Dominguez","year":"1997","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/bs.pmbts.2018.12.003_bb0320","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1172\/JCI200113560","article-title":"Heparan sulfate proteoglycans: intricate molecules with intriguing functions","volume":"108","author":"Iozzo","year":"2001","journal-title":"J Clin Invest"},{"issue":"11","key":"10.1016\/bs.pmbts.2018.12.003_bb0325","doi-asserted-by":"crossref","first-page":"6924","DOI":"10.1074\/jbc.M512932200","article-title":"Inhibition or activation of Apert syndrome FGFR2 (S252W) signaling by specific glycosaminoglycans","volume":"281","author":"McDowell","year":"2006","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/bs.pmbts.2018.12.003_bb0330","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/ijc.11252","article-title":"Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors","volume":"106","author":"Franzmann","year":"2003","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/bs.pmbts.2018.12.003_bb0335","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/bjs.9343","article-title":"Preoperative serum hyaluronic acid level as a prognostic factor in patients undergoing hepatic resection for hepatocellular carcinoma","volume":"101","author":"Mima","year":"2014","journal-title":"Br J Surg"},{"issue":"7","key":"10.1016\/bs.pmbts.2018.12.003_bb0340","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1002\/cncr.20902","article-title":"Detection of bladder carcinoma by combined testing of urine for hyaluronidase and cytokeratin 20 RNAs","volume":"103","author":"Eissa","year":"2005","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/bs.pmbts.2018.12.003_bb0345","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.eururo.2011.05.053","article-title":"Urine markers for detection and surveillance of non-muscle-invasive bladder cancer","volume":"60","author":"Tilki","year":"2011","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/bs.pmbts.2018.12.003_bb0350","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0022-5347(05)68050-0","article-title":"Urinary hyaluronic acid and hyaluronidase: markers for bladder cancer detection and evaluation of grade","volume":"163","author":"Lokeshwar","year":"2000","journal-title":"J Urol"},{"issue":"11","key":"10.1016\/bs.pmbts.2018.12.003_bb0355","first-page":"2965","article-title":"Localization and characterization of melanoma-associated glycosaminoglycans: differential expression of chondroitin and heparan sulfate epitopes in melanoma","volume":"63","author":"Smetsers","year":"2003","journal-title":"Cancer Res"},{"issue":"5\u20136","key":"10.1016\/bs.pmbts.2018.12.003_bb0360","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1159\/000113145","article-title":"Elevate level of glycosaminoglycans and altered sulfation pattern of chondroitin sulfate are associated with differentiation status and histological type of human primary hepatic carcinoma","volume":"72","author":"Lv","year":"2007","journal-title":"Oncology"},{"issue":"4","key":"10.1016\/bs.pmbts.2018.12.003_bb0365","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/jb\/mvj181","article-title":"Raised serum chondroitin sulfate epitope level in ovarian epithelial cancer","volume":"140","author":"Pothacharoen","year":"2006","journal-title":"J Biochem"},{"issue":"10","key":"10.1016\/bs.pmbts.2018.12.003_bb0370","first-page":"2324","article-title":"Elevated levels of peritumoral chondroitin sulfate are predictive of poor prognosis in patients treated by radical prostatectomy for early-stage prostate cancer","volume":"59","author":"Ricciardelli","year":"1999","journal-title":"Cancer Res"},{"issue":"8","key":"10.1016\/bs.pmbts.2018.12.003_bb0375","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1158\/0008-5472.CAN-11-1351","article-title":"Dermatan sulfate is involved in the tumorigenic properties of esophagus squamous cell carcinoma","volume":"72","author":"Thelin","year":"2012","journal-title":"Cancer Res"},{"issue":"11","key":"10.1016\/bs.pmbts.2018.12.003_bb0380","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1002\/1097-0142(19870601)59:11<1931::AID-CNCR2820591116>3.0.CO;2-7","article-title":"Keratan sulfate levels in sera of patients bearing cartilage tumors","volume":"59","author":"Kliner","year":"1987","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/bs.pmbts.2018.12.003_bb0385","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/BF02331382","article-title":"Simultaneous expression of keratan sulphate epitope (a sulphated poly-N-acetyllactosamine) and blood group ABH antigens in papillary carcinomas of the human thyroid gland","volume":"28","author":"Ito","year":"1996","journal-title":"Histochem J"},{"issue":"4","key":"10.1016\/bs.pmbts.2018.12.003_bb0390","first-page":"773","article-title":"Tumor-associated hyaluronic acid: a new sensitive and specific urine marker for bladder cancer","volume":"57","author":"Lokeshwar","year":"1997","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/bs.pmbts.2018.12.003_bb0395","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00029330-200802020-00009","article-title":"Serum hyaluronan levels in oral cancer patients","volume":"121","author":"Xing","year":"2008","journal-title":"Chin Med J"},{"issue":"15","key":"10.1016\/bs.pmbts.2018.12.003_bb0400","doi-asserted-by":"crossref","first-page":"11922","DOI":"10.1074\/jbc.M008432200","article-title":"Stromal and epithelial expression of tumor markers hyaluronic acid and HYAL1 hyaluronidase in prostate cancer","volume":"276","author":"Lokeshwar","year":"2001","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/bs.pmbts.2018.12.003_bb0405","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/ijc.2910460309","article-title":"Serum hyaluronan (hyaluronic acid) in breast cancer patients","volume":"46","author":"Delpech","year":"1990","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/bs.pmbts.2018.12.003_bb0410","first-page":"161","article-title":"A research on serum, urine and tumor tissue hyaluronate assays for detecting malignant ovarian tumors","volume":"30","author":"He","year":"1995","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"10.1016\/bs.pmbts.2018.12.003_bb0415","first-page":"187","article-title":"Hyaluronan and angiogenesis","volume":"143","author":"West","year":"1989","journal-title":"Ciba Found Symp"},{"issue":"1","key":"10.1016\/bs.pmbts.2018.12.003_bb0420","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/cncr.10652","article-title":"Bladder tumor markers for monitoring recurrence and screening comparison of hyaluronic acid-hyaluronidase and BTA-Stat tests","volume":"95","author":"Lokeshwar","year":"2002","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/bs.pmbts.2018.12.003_bb0425","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/dvdy.24555","article-title":"Diverse roles for glycosaminoglycans in neural patterning","volume":"247","author":"Saied-Santiago","year":"2018","journal-title":"Dev Dyn"},{"issue":"30","key":"10.1016\/bs.pmbts.2018.12.003_bb0430","doi-asserted-by":"crossref","first-page":"22966","DOI":"10.1074\/jbc.M109.063735","article-title":"Chemically oversulfated glycosaminoglycans are potent modulators of contact system activation and different cell signaling pathways","volume":"285","author":"Pan","year":"2010","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/bs.pmbts.2018.12.003_bb0435","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1074\/jbc.273.1.51","article-title":"Heparan sulfate undergoes specific structural changes during the progression from human colon adenoma to carcinoma in vitro","volume":"273","author":"Jayson","year":"1998","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/bs.pmbts.2018.12.003_bb0440","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ejca.2010.10.024","article-title":"Glypican-3: a new target for cancer immunotherapy","volume":"47","author":"Ho","year":"2011","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/bs.pmbts.2018.12.003_bb0445","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1177\/1724600818784409","article-title":"Diagnosis accuracy of serum glypican-3 level in patients with hepatocellular carcinoma: a systematic review with meta-analysis","volume":"33","author":"Li","year":"2018","journal-title":"Int J Biol Markers"},{"issue":"4","key":"10.1016\/bs.pmbts.2018.12.003_bb0450","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF03260065","article-title":"Glypican-3 and alpha-fetoprotein as diagnostic tests for hepatocellular carcinoma","volume":"8","author":"Filmus","year":"2004","journal-title":"Mol Diagn"},{"issue":"12","key":"10.1016\/bs.pmbts.2018.12.003_bb0455","first-page":"5055","article-title":"Up-regulation of glypican-3 in human hepatocellular carcinoma","volume":"30","author":"Suzuki","year":"2010","journal-title":"Anticancer Res"},{"issue":"14","key":"10.1016\/bs.pmbts.2018.12.003_bb0460","first-page":"5562","article-title":"Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells","volume":"61","author":"Matsuda","year":"2001","journal-title":"Cancer Res"},{"issue":"7559","key":"10.1016\/bs.pmbts.2018.12.003_bb0465","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature14581","article-title":"Glypican-1 identifies cancer exosomes and detects early pancreatic cancer","volume":"523","author":"Melo","year":"2015","journal-title":"Nature"},{"issue":"6","key":"10.1016\/bs.pmbts.2018.12.003_bb0470","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.3892\/ol.2013.1622","article-title":"The overexpression of glypican-5 promotes cancer cell migration and is associated with shorter overall survival in non-small cell lung cancer","volume":"6","author":"Li","year":"2013","journal-title":"Oncol Lett"},{"issue":"11","key":"10.1016\/bs.pmbts.2018.12.003_bb0475","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/labinvest.3700475","article-title":"Agrin, a novel basement membrane component in human and rat liver, accumulates in cirrhosis and hepatocellular carcinoma","volume":"86","author":"Tatrai","year":"2006","journal-title":"Lab Investig"},{"issue":"9","key":"10.1016\/bs.pmbts.2018.12.003_bb0480","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.humpath.2009.10.029","article-title":"Agrin immunohistochemistry facilitates the determination of primary versus metastatic origin of liver carcinomas","volume":"41","author":"Somoracz","year":"2010","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1016\/bs.pmbts.2018.12.003_bb0485","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1182\/blood.V95.2.388","article-title":"Serum syndecan-1: a new independent prognostic marker in multiple myeloma","volume":"95","author":"Seidel","year":"2000","journal-title":"Blood"},{"key":"10.1016\/bs.pmbts.2018.12.003_bb0490","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1476-4598-5-9","article-title":"Perlecan, a candidate gene for the CAPB locus, regulates prostate cancer cell growth via the Sonic Hedgehog pathway","volume":"5","author":"Datta","year":"2006","journal-title":"Mol Cancer"},{"issue":"22","key":"10.1016\/bs.pmbts.2018.12.003_bb0495","first-page":"5771","article-title":"Abnormal expression of perlecan proteoglycan in metastatic melanomas","volume":"54","author":"Cohen","year":"1994","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/bs.pmbts.2018.12.003_bb0500","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/prca.200780049","article-title":"Identification of circulating endorepellin LG3 fragment: potential use as a serological biomarker for breast cancer","volume":"2","author":"Chang","year":"2008","journal-title":"Proteomics Clin Appl"},{"issue":"8","key":"10.1016\/bs.pmbts.2018.12.003_bb0505","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1158\/0008-5472.CAN-10-3557","article-title":"Serglycin is a theranostic target in nasopharyngeal carcinoma that promotes metastasis","volume":"71","author":"Li","year":"2011","journal-title":"Cancer Res"},{"issue":"10","key":"10.1016\/bs.pmbts.2018.12.003_bb0510","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078157","article-title":"Serglycin is implicated in the promotion of aggressive phenotype of breast cancer cells","volume":"8","author":"Korpetinou","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/bs.pmbts.2018.12.003_bb0515","doi-asserted-by":"crossref","first-page":"266","DOI":"10.5732\/cjc.012.10301","article-title":"Biological functions of decorin in cancer","volume":"32","author":"Bi","year":"2013","journal-title":"Chin J Cancer"},{"issue":"31","key":"10.1016\/bs.pmbts.2018.12.003_bb0520","doi-asserted-by":"crossref","first-page":"4765","DOI":"10.1038\/sj.onc.1205595","article-title":"Decorin suppresses tumor cell-mediated angiogenesis","volume":"21","author":"Grant","year":"2002","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/bs.pmbts.2018.12.003_bb0525","doi-asserted-by":"crossref","first-page":"844","DOI":"10.2353\/ajpath.2008.080275","article-title":"An antimetastatic role for decorin in breast cancer","volume":"173","author":"Goldoni","year":"2008","journal-title":"Am J Pathol"},{"issue":"6","key":"10.1016\/bs.pmbts.2018.12.003_bb0530","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.3892\/or.2012.2040","article-title":"Significance of stromal decorin expression during the progression of breast cancer","volume":"28","author":"Oda","year":"2012","journal-title":"Oncol Rep"},{"issue":"10","key":"10.1016\/bs.pmbts.2018.12.003_bb0535","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076190","article-title":"Lack of decorin expression by human bladder cancer cells offers new tools in the therapy of urothelial malignancies","volume":"8","author":"Sainio","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/bs.pmbts.2018.12.003_bb0540","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10238-011-0155-4","article-title":"Up-regulated biglycan expression correlates with the malignancy in human colorectal cancers","volume":"12","author":"Gu","year":"2012","journal-title":"Clin Exp Med"},{"issue":"11","key":"10.1016\/bs.pmbts.2018.12.003_bb0545","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080084","article-title":"Inhibitory role of the small leucine-rich proteoglycan biglycan in bladder cancer","volume":"8","author":"Niedworok","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/bs.pmbts.2018.12.003_bb0550","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1053\/gast.2001.27222","article-title":"Biglycan is overexpressed in pancreatic cancer and induces G1-arrest in pancreatic cancer cell lines","volume":"121","author":"Weber","year":"2001","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/bs.pmbts.2018.12.003_bb0555","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1258\/ebm.2011.011124","article-title":"Biglycan expression correlates with aggressiveness and poor prognosis of gastric cancer","volume":"236","author":"Wang","year":"2011","journal-title":"Exp Biol Med"},{"issue":"3","key":"10.1016\/bs.pmbts.2018.12.003_bb0560","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00404-013-3017-3","article-title":"Expression and significance of biglycan in endometrial cancer","volume":"289","author":"Liu","year":"2014","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"10.1016\/bs.pmbts.2018.12.003_bb0565","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/ijc.11423","article-title":"Versican in epithelial ovarian cancer: relation to hyaluronan, clinicopathologic factors and prognosis","volume":"107","author":"Voutilainen","year":"2003","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/bs.pmbts.2018.12.003_bb0570","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ygyno.2010.05.029","article-title":"Up-regulation of stromal versican expression in advanced stage serous ovarian cancer","volume":"119","author":"Ghosh","year":"2010","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/bs.pmbts.2018.12.003_bb0575","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.humpath.2004.10.010","article-title":"Versican in nonsmall cell lung cancer: relation to hyaluronan, clinicopathologic factors, and prognosis","volume":"36","author":"Pirinen","year":"2005","journal-title":"Hum Pathol"},{"issue":"8","key":"10.1016\/bs.pmbts.2018.12.003_bb0580","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.bbagen.2006.03.021","article-title":"The greatly increased amounts of accumulated versican and decorin with specific post-translational modifications may be closely associated with the malignant phenotype of pancreatic cancer","volume":"1760","author":"Skandalis","year":"2006","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"10.1016\/bs.pmbts.2018.12.003_bb0585","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0925-4439(02)00161-8","article-title":"Human colon adenocarcinoma is associated with specific post-translational modifications of versican and decorin","volume":"1588","author":"Theocharis","year":"2002","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"10.1016\/bs.pmbts.2018.12.003_bb0590","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.ejca.2007.02.007","article-title":"Versican expression in human cervical cancer","volume":"43","author":"Kodama","year":"2007","journal-title":"Eur J Cancer"},{"issue":"1A","key":"10.1016\/bs.pmbts.2018.12.003_bb0595","first-page":"245","article-title":"Stage-related decorin and versican expression in human laryngeal cancer","volume":"28","author":"Stylianou","year":"2008","journal-title":"Anticancer Res"},{"issue":"4","key":"10.1016\/bs.pmbts.2018.12.003_bb0600","first-page":"1054","article-title":"Regulation of stromal versican expression by breast cancer cells and importance to relapse-free survival in patients with node-negative primary breast cancer","volume":"8","author":"Ricciardelli","year":"2002","journal-title":"Clin Cancer Res"},{"issue":"11","key":"10.1016\/bs.pmbts.2018.12.003_bb0605","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1002\/ijc.28906","article-title":"Reduced promoter methylation and increased expression of CSPG4 negatively influences survival of HNSCC patients","volume":"135","author":"Warta","year":"2014","journal-title":"Int J Cancer"},{"issue":"10","key":"10.1016\/bs.pmbts.2018.12.003_bb0610","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1245\/s10434-010-1037-9","article-title":"Overexpression of endothelial cell specific molecule-1 (ESM-1) in gastric cancer","volume":"17","author":"Liu","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1016\/bs.pmbts.2018.12.003_bb0615","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1111\/j.1349-7006.2010.01665.x","article-title":"Identification of endothelial cell-specific molecule-1 as a potential serum marker for colorectal cancer","volume":"101","author":"Ji","year":"2010","journal-title":"Cancer Sci"},{"issue":"6","key":"10.1016\/bs.pmbts.2018.12.003_bb0620","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1007\/s00404-013-2863-3","article-title":"Clinicopathological correlation of endocan expression and survival in epithelial ovarian cancer","volume":"288","author":"El Behery","year":"2013","journal-title":"Arch Gynecol Obstet"},{"issue":"15","key":"10.1016\/bs.pmbts.2018.12.003_bb0625","doi-asserted-by":"crossref","first-page":"4575","DOI":"10.1158\/1078-0432.CCR-06-0185","article-title":"Endocan expression and relationship with survival in human non-small cell lung cancer","volume":"12","author":"Grigoriu","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/bs.pmbts.2018.12.003_bb0630","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/NEN.0b013e3181a52a7f","article-title":"Endocan expression and localization in human glioblastomas","volume":"68","author":"Maurage","year":"2009","journal-title":"J Neuropathol Exp Neurol"},{"issue":"6","key":"10.1016\/bs.pmbts.2018.12.003_bb0635","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1750-3639.2012.00578.x","article-title":"Endothelial expression of endocan is strongly associated with tumor progression in pituitary adenoma","volume":"22","author":"Cornelius","year":"2012","journal-title":"Brain Pathol"},{"issue":"7","key":"10.1016\/bs.pmbts.2018.12.003_bb0640","first-page":"1348","article-title":"Expression of lumican in human breast carcinoma","volume":"58","author":"Leygue","year":"1998","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/bs.pmbts.2018.12.003_bb0645","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3390\/cancers2010133","article-title":"Overexpression of periostin and lumican in esophageal squamous cell carcinoma","volume":"2","author":"Kashyap","year":"2010","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/bs.pmbts.2018.12.003_bb0650","first-page":"1177","article-title":"Expression and roles of lumican in lung adenocarcinoma and squamous cell carcinoma","volume":"33","author":"Matsuda","year":"2008","journal-title":"Int J Oncol"},{"issue":"3","key":"10.1016\/bs.pmbts.2018.12.003_bb0655","first-page":"537","article-title":"Role of lumican in cancer cells and adjacent stromal tissues in human pancreatic cancer","volume":"18","author":"Ishiwata","year":"2007","journal-title":"Oncol Rep"},{"issue":"12","key":"10.1016\/bs.pmbts.2018.12.003_bb0660","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.1182\/blood-2004-10-3941","article-title":"Fibromodulin, an extracellular matrix protein: characterization of its unique gene and protein expression in B-cell chronic lymphocytic leukemia and mantle cell lymphoma","volume":"105","author":"Mikaelsson","year":"2005","journal-title":"Blood"},{"issue":"1","key":"10.1016\/bs.pmbts.2018.12.003_bb0665","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00795-008-0429-4","article-title":"Ultrastructural immunolocalization of a cartilage-specific proteoglycan, aggrecan, in salivary pleomorphic adenomas","volume":"42","author":"Muramatsu","year":"2009","journal-title":"Med Mol Morphol"},{"key":"10.1016\/bs.pmbts.2018.12.003_bb0670","first-page":"680136","article-title":"Proteoglycan expression in normal human prostate tissue and prostate cancer","volume":"2013","author":"Suhovskih","year":"2013","journal-title":"ISRN Oncol"},{"issue":"7","key":"10.1016\/bs.pmbts.2018.12.003_bb0675","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.bbagen.2006.02.007","article-title":"Cartilage aggrecan undergoes significant compositional and structural alterations during laryngeal cancer","volume":"1760","author":"Skandalis","year":"2006","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"10.1016\/bs.pmbts.2018.12.003_bb0680","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1530\/eje.1.01849","article-title":"Inhibin alpha-subunit and the inhibin coreceptor betaglycan are downregulated in endometrial carcinoma","volume":"152","author":"Florio","year":"2005","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"10.1016\/bs.pmbts.2018.12.003_bb0685","doi-asserted-by":"crossref","first-page":"5231","DOI":"10.1158\/0008-5472.CAN-07-0035","article-title":"Loss of betaglycan expression in ovarian cancer: role in motility and invasion","volume":"67","author":"Hempel","year":"2007","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/bs.pmbts.2018.12.003_bb0690","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/carcin\/bgm289","article-title":"TbetaRIII suppresses non-small cell lung cancer invasiveness and tumorigenicity","volume":"29","author":"Finger","year":"2008","journal-title":"Carcinogenesis"},{"issue":"27","key":"10.1016\/bs.pmbts.2018.12.003_bb0695","doi-asserted-by":"crossref","first-page":"19006","DOI":"10.18632\/oncotarget.24873","article-title":"Glypican-1 is enriched in circulating-exosomes in pancreatic cancer and correlates with tumor burden","volume":"9","author":"Frampton","year":"2018","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/bs.pmbts.2018.12.003_bb0700","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/jcla.20484","article-title":"Diagnostic and prognostic role of serum glypican 3 in patients with hepatocellular carcinoma","volume":"25","author":"Ozkan","year":"2011","journal-title":"J Clin Lab Anal"},{"issue":"1","key":"10.1016\/bs.pmbts.2018.12.003_bb0705","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2014.12.003","article-title":"Advances in the molecular functions of syndecan-1 (SDC1\/CD138) in the pathogenesis of malignancies","volume":"94","author":"Gharbaran","year":"2015","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/bs.pmbts.2018.12.003_bb0710","doi-asserted-by":"crossref","first-page":"356128","DOI":"10.1100\/2012\/356128","article-title":"Prognostic value of hepatocyte growth factor, syndecan-1, and osteopontin in multiple myeloma and monoclonal gammopathy of undetermined significance","volume":"2012","author":"Minarik","year":"2012","journal-title":"ScientificWorldJournal"},{"issue":"2","key":"10.1016\/bs.pmbts.2018.12.003_bb0715","doi-asserted-by":"crossref","first-page":"115","DOI":"10.5045\/kjh.2010.45.2.115","article-title":"Soluble syndecan-1 at diagnosis and during follow up of multiple myeloma: a single institution study","volume":"45","author":"Kim","year":"2010","journal-title":"Korean J Hematol"},{"issue":"4","key":"10.1016\/bs.pmbts.2018.12.003_bb0720","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.humpath.2013.10.036","article-title":"Enhanced stromal syndecan-1 expression is an independent risk factor for poor survival in bladder cancer","volume":"45","author":"Szarvas","year":"2014","journal-title":"Hum Pathol"},{"issue":"5","key":"10.1016\/bs.pmbts.2018.12.003_bb0725","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10585-005-2339-3","article-title":"Perlecan knockdown in metastatic prostate cancer cells reduces heparin-binding growth factor responses in vitro and tumor growth in vivo","volume":"22","author":"Savore","year":"2005","journal-title":"Clin Exp Metastasis"},{"issue":"22","key":"10.1016\/bs.pmbts.2018.12.003_bb0730","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1093\/jnci\/djj441","article-title":"Endorepellin in vivo: targeting the tumor vasculature and retarding cancer growth and metabolism","volume":"98","author":"Bix","year":"2006","journal-title":"J Natl Cancer Inst"},{"issue":"pt 3","key":"10.1016\/bs.pmbts.2018.12.003_bb0735","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1042\/bj3150815","article-title":"Betaglycan has multiple binding sites for transforming growth factor-beta 1","volume":"315","author":"Kaname","year":"1996","journal-title":"Biochem J"},{"issue":"4","key":"10.1016\/bs.pmbts.2018.12.003_bb0740","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1210\/me.2008-0300","article-title":"Loss of betaglycan contributes to the malignant properties of human granulosa tumor cells","volume":"23","author":"Bilandzic","year":"2009","journal-title":"Mol Endocrinol"},{"issue":"7\u20138","key":"10.1016\/bs.pmbts.2018.12.003_bb0745","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s00018-007-7455-6","article-title":"Serglycin\u2014structure and biology","volume":"65","author":"Kolset","year":"2008","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"10.1016\/bs.pmbts.2018.12.003_bb0750","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/hed.23841","article-title":"Serglycin expression: an independent marker of distant metastases in nasopharyngeal carcinoma","volume":"38","author":"Chia","year":"2016","journal-title":"Head Neck"},{"issue":"2","key":"10.1016\/bs.pmbts.2018.12.003_bb0755","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ajpath.2012.04.029","article-title":"Decorin: a guardian from the matrix","volume":"181","author":"Neill","year":"2012","journal-title":"Am J Pathol"},{"issue":"19","key":"10.1016\/bs.pmbts.2018.12.003_bb0760","doi-asserted-by":"crossref","first-page":"11389","DOI":"10.1016\/S0021-9258(19)38605-3","article-title":"Altered expression of chondroitin sulfate proteoglycan in the stroma of human colon carcinoma. Hypomethylation of PG-40 gene correlates with increased PG-40 content and mRNA levels","volume":"265","author":"Adany","year":"1990","journal-title":"J Biol Chem"},{"issue":"8","key":"10.1016\/bs.pmbts.2018.12.003_bb0765","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042516","article-title":"Stromal expression of decorin, Semaphorin6D, SPARC, Sprouty1 and Tsukushi in developing prostate and decreased levels of decorin in prostate cancer","volume":"7","author":"Henke","year":"2012","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/bs.pmbts.2018.12.003_bb0770","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13277-016-5431-1","article-title":"Reduced decorin expression in the tumor stroma correlates with tumor proliferation and predicts poor prognosis in patients with I-IIIA non-small cell lung cancer","volume":"37","author":"Hong","year":"2016","journal-title":"Tumour Biol"},{"issue":"5","key":"10.1016\/bs.pmbts.2018.12.003_bb0775","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1007\/s13277-014-2968-8","article-title":"Decorin is responsible for progression of non-small-cell lung cancer by promoting cell proliferation and metastasis","volume":"36","author":"Shi","year":"2015","journal-title":"Tumour Biol"},{"issue":"1","key":"10.1016\/bs.pmbts.2018.12.003_bb0780","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5301\/JBM.2011.6372","article-title":"Decreased expression of decorin and p57(KIP2) correlates with poor survival and lymphatic metastasis in lung cancer patients","volume":"26","author":"Biaoxue","year":"2011","journal-title":"Int J Biol Markers"},{"issue":"12","key":"10.1016\/bs.pmbts.2018.12.003_bb0785","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1002\/emmm.201302655","article-title":"An essential role for decorin in bladder cancer invasiveness","volume":"5","author":"El Behi","year":"2013","journal-title":"EMBO Mol Med"},{"key":"10.1016\/bs.pmbts.2018.12.003_bb0790","first-page":"1","article-title":"iTRAQ-based proteomic analysis of DMH-induced colorectal cancer in mice reveals the expressions of beta-catenin, decorin, septin-7, and S100A10 expression in 53 cases of human hereditary polyposis colorectal cancer","author":"Liu","year":"2018","journal-title":"Clin Transl Oncol"},{"issue":"2","key":"10.1016\/bs.pmbts.2018.12.003_bb0795","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/carcin\/bgr293","article-title":"Decorin-mediated inhibition of colorectal cancer growth and migration is associated with E-cadherin in vitro and in mice","volume":"33","author":"Bi","year":"2012","journal-title":"Carcinogenesis"},{"issue":"1\u20132","key":"10.1016\/bs.pmbts.2018.12.003_bb0800","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s11010-018-3365-1","article-title":"Biglycan promotes the chemotherapy resistance of colon cancer by activating NF-kappaB signal transduction","volume":"449","author":"Liu","year":"2018","journal-title":"Mol Cell Biochem"},{"issue":"9","key":"10.1016\/bs.pmbts.2018.12.003_bb0805","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.neo.2017.06.003","article-title":"Up-regulation of Biglycan is associated with poor prognosis and PTEN deletion in patients with prostate Cancer","volume":"19","author":"Jacobsen","year":"2017","journal-title":"Neoplasia"},{"issue":"2","key":"10.1016\/bs.pmbts.2018.12.003_bb0810","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00404-015-3844-5","article-title":"Biglycan enhances the ability of migration and invasion in endometrial cancer","volume":"293","author":"Sun","year":"2016","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"10.1016\/bs.pmbts.2018.12.003_bb0815","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1007\/s13277-014-2779-y","article-title":"Biglycan up-regulated vascular endothelial growth factor (VEGF) expression and promoted angiogenesis in colon cancer","volume":"36","author":"Xing","year":"2015","journal-title":"Tumour Biol"},{"issue":"7","key":"10.1016\/bs.pmbts.2018.12.003_bb0820","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.18632\/oncotarget.1871","article-title":"Biglycan enhances gastric cancer invasion by activating FAK signaling pathway","volume":"5","author":"Hu","year":"2014","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/bs.pmbts.2018.12.003_bb0825","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1039\/c3ib40103k","article-title":"Breast cancer normalization induced by embryonic mesenchyme is mediated by extracellular matrix biglycan","volume":"5","author":"Bischof","year":"2013","journal-title":"Integr Biol"},{"issue":"10","key":"10.1016\/bs.pmbts.2018.12.003_bb0830","doi-asserted-by":"crossref","first-page":"5955","DOI":"10.1074\/jbc.273.10.5955","article-title":"A role of chondroitin sulfate glycosaminoglycan binding site in alpha4beta1 integrin-mediated melanoma cell adhesion","volume":"273","author":"Iida","year":"1998","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/bs.pmbts.2018.12.003_bb0835","first-page":"701","article-title":"Roles of versican in cancer biology\u2014tumorigenesis, progression and metastasis","volume":"28","author":"Du","year":"2013","journal-title":"Histol Histopathol"},{"issue":"1\u20132","key":"10.1016\/bs.pmbts.2018.12.003_bb0840","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10555-009-9182-y","article-title":"The biological role and regulation of versican levels in cancer","volume":"28","author":"Ricciardelli","year":"2009","journal-title":"Cancer Metastasis Rev"},{"issue":"2","key":"10.1016\/bs.pmbts.2018.12.003_bb0845","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1177\/147323001003800213","article-title":"Over-expression of the endocan gene in endothelial cells from hepatocellular carcinoma is associated with angiogenesis and tumour invasion","volume":"38","author":"Chen","year":"2010","journal-title":"J Int Med Res"},{"issue":"3","key":"10.1016\/bs.pmbts.2018.12.003_bb0850","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s00726-010-0729-6","article-title":"ESM-1 silencing decreased cell survival, migration, and invasion and modulated cell cycle progression in hepatocellular carcinoma","volume":"40","author":"Kang","year":"2011","journal-title":"Amino Acids"},{"issue":"2","key":"10.1016\/bs.pmbts.2018.12.003_bb0855","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10620-008-0346-3","article-title":"Endocan expression correlated with poor survival in human hepatocellular carcinoma","volume":"54","author":"Huang","year":"2009","journal-title":"Dig Dis Sci"},{"key":"10.1016\/bs.pmbts.2018.12.003_bb0860","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2147\/CEG.S171339","article-title":"Serum human endothelial cell-specific molecule-1 (endocan) and vascular endothelial growth factor in cirrhotic HCV patients with hepatocellular carcinoma as predictors of mortality","volume":"11","author":"Youssef","year":"2018","journal-title":"Clin Exp Gastroenterol"},{"issue":"23","key":"10.1016\/bs.pmbts.2018.12.003_bb0865","doi-asserted-by":"crossref","first-page":"5422","DOI":"10.3748\/wjg.v22.i23.5422","article-title":"Endocan-expressing microvessel density as a prognostic factor for survival in human gastric cancer","volume":"22","author":"Chang","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"10","key":"10.1016\/bs.pmbts.2018.12.003_bb0870","doi-asserted-by":"crossref","first-page":"10043","DOI":"10.1007\/s13277-014-2287-0","article-title":"Biological and clinical implications of endocan in gastric cancer","volume":"35","author":"Zhao","year":"2014","journal-title":"Tumour Biol"},{"issue":"5","key":"10.1016\/bs.pmbts.2018.12.003_bb0875","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.3892\/or.2012.2012","article-title":"Expression of endothelial cell-specific molecule-1 regulated by hypoxia inducible factor-1alpha in human colon carcinoma: impact of ESM-1 on prognosis and its correlation with clinicopathological features","volume":"28","author":"Kim","year":"2012","journal-title":"Oncol Rep"},{"issue":"5","key":"10.1016\/bs.pmbts.2018.12.003_bb0880","doi-asserted-by":"crossref","first-page":"e22079","DOI":"10.1002\/jcla.22079","article-title":"Serum endocan levels in endometrial and ovarian cancers","volume":"31","author":"Laloglu","year":"2017","journal-title":"J Clin Lab Anal"},{"issue":"6","key":"10.1016\/bs.pmbts.2018.12.003_bb0885","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1177\/0004563216645623","article-title":"Serum and urinary endocan levels for bladder cancer diagnosis","volume":"53","author":"Hu","year":"2016","journal-title":"Ann Clin Biochem"},{"issue":"6","key":"10.1016\/bs.pmbts.2018.12.003_bb0890","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1177\/0004563216629169","article-title":"The determination of serum and urinary endocan concentrations in patients with bladder cancer","volume":"53","author":"Laloglu","year":"2016","journal-title":"Ann Clin Biochem"},{"issue":"1","key":"10.1016\/bs.pmbts.2018.12.003_bb0895","doi-asserted-by":"crossref","first-page":"662","DOI":"10.18632\/oncotarget.23087","article-title":"Clinical validation of serum endocan (ESM-1) as a potential biomarker in patients with renal cell carcinoma","volume":"9","author":"Kim","year":"2018","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/bs.pmbts.2018.12.003_bb0900","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1365-2559.2009.03458.x","article-title":"Vascular endocan (ESM-1) is markedly overexpressed in clear cell renal cell carcinoma","volume":"56","author":"Leroy","year":"2010","journal-title":"Histopathology"},{"issue":"2","key":"10.1016\/bs.pmbts.2018.12.003_bb0905","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10549-016-4057-8","article-title":"Endocan as a prognostic biomarker of triple-negative breast cancer","volume":"161","author":"Sagara","year":"2017","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"10.1016\/bs.pmbts.2018.12.003_bb0910","first-page":"5235","article-title":"Lumican expression in gastric cancer and its association with biological behavior and prognosis","volume":"14","author":"Chen","year":"2017","journal-title":"Oncol Lett"},{"key":"10.1016\/bs.pmbts.2018.12.003_bb0915","doi-asserted-by":"crossref","first-page":"45138","DOI":"10.1038\/srep45138","article-title":"Lumican effectively regulates the estrogen receptors-associated functional properties of breast cancer cells, expression of matrix effectors and epithelial-to-mesenchymal transition","volume":"7","author":"Karamanou","year":"2017","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/bs.pmbts.2018.12.003_bb0920","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134111","article-title":"Microenvironmental modulation of decorin and lumican in temozolomide-resistant glioblastoma and neuroblastoma cancer stem-like cells","volume":"10","author":"Farace","year":"2015","journal-title":"PLoS One"},{"issue":"24","key":"10.1016\/bs.pmbts.2018.12.003_bb0925","doi-asserted-by":"crossref","first-page":"6529","DOI":"10.1158\/1078-0432.CCR-14-0970","article-title":"Extracellular lumican inhibits pancreatic cancer cell growth and is associated with prolonged survival after surgery","volume":"20","author":"Li","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"7","key":"10.1016\/bs.pmbts.2018.12.003_bb0930","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.yexcr.2013.01.023","article-title":"Lumican expression, localization and antitumor activity in prostate cancer","volume":"319","author":"Coulson-Thomas","year":"2013","journal-title":"Exp Cell Res"},{"issue":"suppl 3","key":"10.1016\/bs.pmbts.2018.12.003_bb0935","doi-asserted-by":"crossref","first-page":"S348","DOI":"10.1245\/s10434-012-2441-0","article-title":"Lumican and versican are associated with good outcome in stage II and III colon cancer","volume":"20","author":"de Wit","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/bs.pmbts.2018.12.003_bb0940","first-page":"943","article-title":"Expression and accumulation of lumican protein in uterine cervical cancer cells at the periphery of cancer nests","volume":"20","author":"Naito","year":"2002","journal-title":"Int J Oncol"},{"issue":"3","key":"10.1016\/bs.pmbts.2018.12.003_bb0945","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/path.1037","article-title":"Lumican expression in alpha cells of islets in pancreas and pancreatic cancer cells","volume":"196","author":"Ping Lu","year":"2002","journal-title":"J Pathol"},{"issue":"4\u20135","key":"10.1016\/bs.pmbts.2018.12.003_bb0950","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1023\/A:1025348417078","article-title":"Functions of lumican and fibromodulin: lessons from knockout mice","volume":"19","author":"Chakravarti","year":"2002","journal-title":"Glycoconj J"},{"issue":"1","key":"10.1016\/bs.pmbts.2018.12.003_bb0955","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jnci.2011.07.002","article-title":"Study of fibromodulin gene expression in B-cell chronic lymphocytic leukemia","volume":"23","author":"Hassan","year":"2011","journal-title":"J Egypt Natl Canc Inst"},{"issue":"5","key":"10.1016\/bs.pmbts.2018.12.003_bb0960","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3892\/mco.2013.151","article-title":"Overexpression of heparan sulfate 6-O-sulfotransferase-2 in colorectal cancer","volume":"1","author":"Hatabe","year":"2013","journal-title":"Mol Clin Oncol"},{"issue":"2","key":"10.1016\/bs.pmbts.2018.12.003_bb0965","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/sj.onc.1206146","article-title":"Methylation-associated silencing of heparan sulfate D-glucosaminyl 3-O-sulfotransferase-2 (3-OST-2) in human breast, colon, lung and pancreatic cancers","volume":"22","author":"Miyamoto","year":"2003","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/bs.pmbts.2018.12.003_bb0970","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.3892\/ijo.2015.2828","article-title":"CHST11 gene expression and DNA methylation in breast cancer","volume":"46","author":"Herman","year":"2015","journal-title":"Int J Oncol"},{"issue":"8","key":"10.1016\/bs.pmbts.2018.12.003_bb0975","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1158\/1078-0432.CCR-04-0664","article-title":"Heparanase expression at the invasion front of human head and neck cancers and correlation with poor prognosis","volume":"11","author":"Beckhove","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/bs.pmbts.2018.12.003_bb0980","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00432-004-0644-x","article-title":"Heparanase expression correlates with malignant potential in human colon cancer","volume":"131","author":"Nobuhisa","year":"2005","journal-title":"J Cancer Res Clin Oncol"},{"issue":"8","key":"10.1016\/bs.pmbts.2018.12.003_bb0985","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1038\/sj.bjc.6600232","article-title":"Heparanase expression is a prognostic indicator for postoperative survival in pancreatic adenocarcinoma","volume":"86","author":"Rohloff","year":"2002","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/bs.pmbts.2018.12.003_bb0990","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jamcollsurg.2004.10.034","article-title":"Ductal carcinoma in situ of the breast and heparanase-1 expression: a molecular explanation for more aggressive subtypes","volume":"200","author":"Maxhimer","year":"2005","journal-title":"J Am Coll Surg"},{"issue":"6","key":"10.1016\/bs.pmbts.2018.12.003_bb0995","first-page":"961","article-title":"Heparanase messenger RNA expression in epithelial ovarian tumor","volume":"12","author":"Kodama","year":"2003","journal-title":"Int J Mol Med"},{"issue":"25","key":"10.1016\/bs.pmbts.2018.12.003_bb1000","doi-asserted-by":"crossref","first-page":"23107","DOI":"10.1074\/jbc.M302203200","article-title":"Loss of HSulf-1 up-regulates heparin-binding growth factor signaling in cancer","volume":"278","author":"Lai","year":"2003","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/bs.pmbts.2018.12.003_bb1005","doi-asserted-by":"crossref","first-page":"641","DOI":"10.7314\/APJCP.2012.13.2.641","article-title":"Endo-sulfatase Sulf-1 protein expression is down-regulated in gastric cancer","volume":"13","author":"Gopal","year":"2012","journal-title":"Asian Pac J Cancer Prev"},{"issue":"5","key":"10.1016\/bs.pmbts.2018.12.003_bb1010","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/onc.2009.365","article-title":"Sulf-2, a heparan sulfate endosulfatase, promotes human lung carcinogenesis","volume":"29","author":"Lemjabbar-Alaoui","year":"2010","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/bs.pmbts.2018.12.003_bb1015","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1593\/neo.05496","article-title":"Sulf-2, a proangiogenic heparan sulfate endosulfatase, is upregulated in breast cancer","volume":"7","author":"Morimoto-Tomita","year":"2005","journal-title":"Neoplasia"},{"issue":"6","key":"10.1016\/bs.pmbts.2018.12.003_bb1020","doi-asserted-by":"crossref","first-page":"e001624","DOI":"10.1136\/bmjopen-2012-001624","article-title":"SULF2 expression by immunohistochemistry and overall survival in oesophageal cancer: a cohort study","volume":"2","author":"Lui","year":"2012","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/bs.pmbts.2018.12.003_bb1025","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/hep.22202","article-title":"Sulfatase 2 up-regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma","volume":"47","author":"Lai","year":"2008","journal-title":"Hepatology"},{"issue":"15","key":"10.1016\/bs.pmbts.2018.12.003_bb1030","doi-asserted-by":"crossref","first-page":"10488","DOI":"10.1074\/jbc.M113.534263","article-title":"Ovarian cancer cell heparan sulfate 6-O-sulfotransferases regulate an angiogenic program induced by heparin-binding epidermal growth factor (EGF)-like growth factor\/EGF receptor signaling","volume":"289","author":"Cole","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/bs.pmbts.2018.12.003_bb1035","doi-asserted-by":"crossref","first-page":"893208","DOI":"10.1155\/2011\/893208","article-title":"Role of heparan sulfate 2-o-sulfotransferase in prostate cancer cell proliferation, invasion, and growth factor signaling","volume":"2011","author":"Ferguson","year":"2011","journal-title":"Prostate Cancer"},{"issue":"2","key":"10.1016\/bs.pmbts.2018.12.003_bb1040","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1096\/fj.09-136291","article-title":"Epigenetics: methylation-associated repression of heparan sulfate 3-O-sulfotransferase gene expression contributes to the invasive phenotype of H-EMC-SS chondrosarcoma cells","volume":"24","author":"Bui","year":"2010","journal-title":"FASEB J"},{"issue":"11","key":"10.1016\/bs.pmbts.2018.12.003_bb1045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079634","article-title":"Epigenetic inactivation of heparan sulfate (glucosamine) 3-O-sulfotransferase 2 in lung cancer and its role in tumorigenesis","volume":"8","author":"Hwang","year":"2013","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/bs.pmbts.2018.12.003_bb1050","doi-asserted-by":"crossref","first-page":"9023","DOI":"10.1007\/s13277-015-3652-3","article-title":"Prognostic impact of chondroitin-4-sulfotransferase CHST11 in ovarian cancer","volume":"36","author":"Oliveira-Ferrer","year":"2015","journal-title":"Tumour Biol"},{"issue":"3","key":"10.1016\/bs.pmbts.2018.12.003_bb1055","doi-asserted-by":"crossref","first-page":"R58","DOI":"10.1186\/bcr2895","article-title":"Chondroitin sulfates play a major role in breast cancer metastasis: a role for CSPG4 and CHST11 gene expression in forming surface P-selectin ligands in aggressive breast cancer cells","volume":"13","author":"Cooney","year":"2011","journal-title":"Breast Cancer Res"},{"issue":"41","key":"10.1016\/bs.pmbts.2018.12.003_bb1060","doi-asserted-by":"crossref","first-page":"6991","DOI":"10.1038\/sj.onc.1207934","article-title":"Deregulation of the carbohydrate (chondroitin 4) sulfotransferase 11 (CHST11) gene in a B-cell chronic lymphocytic leukemia with a t(12;14)(q23;q32)","volume":"23","author":"Schmidt","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/bs.pmbts.2018.12.003_bb1065","first-page":"60","article-title":"Enzymic pathways of hyaluronan catabolism","volume":"143","author":"Roden","year":"1989","journal-title":"Ciba Found Symp"},{"issue":"4","key":"10.1016\/bs.pmbts.2018.12.003_bb1070","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.semcancer.2008.04.001","article-title":"Hyaluronan in cancer biology","volume":"18","author":"Stern","year":"2008","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/bs.pmbts.2018.12.003_bb1075","first-page":"1","article-title":"The biology of hyaluronan. Introduction","volume":"143","author":"Laurent","year":"1989","journal-title":"Ciba Found Symp"},{"issue":"3","key":"10.1016\/bs.pmbts.2018.12.003_bb1080","first-page":"M99","article-title":"Heparanase: a key enzyme involved in cell invasion","volume":"1471","author":"Parish","year":"2001","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"10.1016\/bs.pmbts.2018.12.003_bb1085","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1177\/0300060517700323","article-title":"Heparanase overexpression down-regulates syndecan-1 expression in a gallbladder carcinoma cell line","volume":"45","author":"Jin","year":"2017","journal-title":"J Int Med Res"},{"issue":"suppl 1","key":"10.1016\/bs.pmbts.2018.12.003_bb1090","doi-asserted-by":"crossref","first-page":"S184","DOI":"10.1016\/S0049-3848(16)30156-6","article-title":"PO-23\u2014expression of heparanase in cancer as biomarker of malignancies: overexpression in an aggressive, poor survival gastric cancer \u201cgastric signet ring cell carcinoma\u201d compared with that of other gastric cancers","volume":"140","author":"Fourgeaud","year":"2016","journal-title":"Thromb Res"},{"issue":"15","key":"10.1016\/bs.pmbts.2018.12.003_bb1095","doi-asserted-by":"crossref","first-page":"6355","DOI":"10.1158\/0008-5472.CAN-09-1195","article-title":"Overexpression of extracellular superoxide dismutase attenuates heparanase expression and inhibits breast carcinoma cell growth and invasion","volume":"69","author":"Teoh","year":"2009","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/bs.pmbts.2018.12.003_bb1100","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1096\/fj.12-226373","article-title":"HSulf sulfatases catalyze processive and oriented 6-O-desulfation of heparan sulfate that differentially regulates fibroblast growth factor activity","volume":"27","author":"Seffouh","year":"2013","journal-title":"FASEB J"},{"key":"10.1016\/bs.pmbts.2018.12.003_bb1105","doi-asserted-by":"crossref","first-page":"41977","DOI":"10.1038\/srep41977","article-title":"Loss of HSulf-1: the missing link between autophagy and lipid droplets in ovarian cancer","volume":"7","author":"Roy","year":"2017","journal-title":"Sci Rep"},{"issue":"32","key":"10.1016\/bs.pmbts.2018.12.003_bb1110","doi-asserted-by":"crossref","first-page":"33705","DOI":"10.18632\/oncotarget.5605","article-title":"HSulf-1 deficiency dictates a metabolic reprograming of glycolysis and TCA cycle in ovarian cancer","volume":"6","author":"Mondal","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/bs.pmbts.2018.12.003_bb1115","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/2049-3002-2-13","article-title":"Loss of HSulf-1 promotes altered lipid metabolism in ovarian cancer","volume":"2","author":"Roy","year":"2014","journal-title":"Cancer Metab"},{"issue":"7","key":"10.1016\/bs.pmbts.2018.12.003_bb1120","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1038\/sj.onc.1207258","article-title":"HSulf-1 modulates HGF-mediated tumor cell invasion and signaling in head and neck squamous carcinoma","volume":"23","author":"Lai","year":"2004","journal-title":"Oncogene"},{"issue":"48","key":"10.1016\/bs.pmbts.2018.12.003_bb1125","doi-asserted-by":"crossref","first-page":"40066","DOI":"10.1074\/jbc.M508136200","article-title":"HSulf-1 and HSulf-2 are potent inhibitors of myeloma tumor growth in vivo","volume":"280","author":"Dai","year":"2005","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/bs.pmbts.2018.12.003_bb1130","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1476-4598-4-14","article-title":"Enhanced levels of Hsulf-1 interfere with heparin-binding growth factor signaling in pancreatic cancer","volume":"4","author":"Li","year":"2005","journal-title":"Mol Cancer"},{"issue":"19","key":"10.1016\/bs.pmbts.2018.12.003_bb1135","doi-asserted-by":"crossref","first-page":"14413","DOI":"10.1074\/jbc.M611395200","article-title":"Loss of HSulf-1 expression enhances autocrine signaling mediated by amphiregulin in breast cancer","volume":"282","author":"Narita","year":"2007","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/bs.pmbts.2018.12.003_bb1140","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.3892\/ol.2011.407","article-title":"HSulf-1 suppresses cell growth and down-regulates hedgehog signaling in human gastric cancer cells","volume":"2","author":"Ma","year":"2011","journal-title":"Oncol Lett"},{"key":"10.1016\/bs.pmbts.2018.12.003_bb1145","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1465-9921-13-69","article-title":"HSULF-1 inhibits ERK and AKT signaling and decreases cell viability in vitro in human lung epithelial cells","volume":"13","author":"Zhang","year":"2012","journal-title":"Respir Res"},{"issue":"13","key":"10.1016\/bs.pmbts.2018.12.003_bb1150","doi-asserted-by":"crossref","first-page":"5029","DOI":"10.18632\/oncotarget.2078","article-title":"Sulfatase 1 (hSulf-1) reverses basic fibroblast growth factor-stimulated signaling and inhibits growth of hepatocellular carcinoma in animal model","volume":"5","author":"Xu","year":"2014","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/bs.pmbts.2018.12.003_bb1155","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/mc.20824","article-title":"Hypoxia negatively regulates heparan sulfatase 2 expression in renal cancer cell lines","volume":"51","author":"Khurana","year":"2012","journal-title":"Mol Carcinog"},{"issue":"9","key":"10.1016\/bs.pmbts.2018.12.003_bb1160","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1517\/14728222.2010.504718","article-title":"Sulf-2: an extracellular modulator of cell signaling and a cancer target candidate","volume":"14","author":"Rosen","year":"2010","journal-title":"Expert Opin Ther Targets"}],"container-title":["Progress in Molecular Biology and Translational Science","Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117318301510?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117318301510?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T04:00:03Z","timestamp":1761796803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877117318301510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9780128177389"],"references-count":231,"URL":"https:\/\/doi.org\/10.1016\/bs.pmbts.2018.12.003","relation":{},"ISSN":["1877-1173"],"issn-type":[{"type":"print","value":"1877-1173"}],"subject":[],"published":{"date-parts":[[2019]]}}}